Insight Molecular Diagnostics (IMDX) Gross Profit (2020 - 2026)
Insight Molecular Diagnostics' Gross Profit came in at $157,000 for Q2 2026, down 53.6% from $338,000 a year earlier but up 946.7% from the prior quarter.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Gross Profit (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Insight Molecular Diagnostics reported Gross Profit of $807,000, down 65.0% year-over-year; for FY2025, it came in at $2.3 million, up 210.5% from FY2024.
- Going back by year, Gross Profit was $740,000 in FY2024 (+79.2%), $413,000 in FY2023, -$18,000 in FY2022 and $1.42 million in FY2021.
- The five-year range for quarterly Gross Profit is -$866,000 (Q3 2021) to $2.6 million (Q4 2021).
- Year-over-year, Gross Profit has declined for three consecutive quarters, with growth averaging 84.2% over the last six quarters.
- The fastest year-over-year change in Gross Profit over five years came in Q2 2023 (growth of 777.4%), and the weakest in Q1 2026 (a decline of 98.9%).
- Business Quant data shows IMDX's Gross Profit at $15,000 (Q1 2026), $496,000 (Q4 2025) and $139,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn |
| 10 | Insight Molecular Diagnostics | 117.12 Mn | 40.83 Mn | 157,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 157,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 496,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 338,000.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 595,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | -117,000.00 |
| Sep 30, 2023 | 248,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | -27,000.00 |
| Sep 30, 2022 | -269,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 247,000.00 |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | -866,000.00 |
API Access
Insight Molecular Diagnostics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();